257 related articles for article (PubMed ID: 33176814)
21. Light and electron microscopic examination of fine-needle aspirates in the preoperative diagnosis of osteogenic tumors: a study of 21 osteosarcomas and two osteoblastomas.
Walaas L; Kindblom LG
Diagn Cytopathol; 1990; 6(1):27-38. PubMed ID: 2323294
[TBL] [Abstract][Full Text] [Related]
22. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
[TBL] [Abstract][Full Text] [Related]
23. Classification of bone tumors.
Bertoni F; Bacchini P
Eur J Radiol; 1998 May; 27 Suppl 1():S74-6. PubMed ID: 9652505
[TBL] [Abstract][Full Text] [Related]
24. Bone Tumors: Primary Bone Cancers.
Keil L
FP Essent; 2020 Jun; 493():22-26. PubMed ID: 32573183
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of β-catenin expression in the differential diagnosis of osteosarcoma, osteoblastoma, and chondroblastoma.
Erdogan KE; Pacheco M; Gambarotti M; Magagnoli G; Sbaraglia M; Frisoni T; Righi A; Dei Tos AP
Virchows Arch; 2021 Sep; 479(3):529-535. PubMed ID: 33511430
[TBL] [Abstract][Full Text] [Related]
26. Role of immunohistochemical cyclo-oxygenase-2 (COX-2) and osteocalcin in differentiating between osteoblastomas and osteosarcomas.
El-Badawi ZH; Muhammad EM; Noaman HH
Malays J Pathol; 2012 Jun; 34(1):15-23. PubMed ID: 22870593
[TBL] [Abstract][Full Text] [Related]
27. Molecular distinction of chondrosarcoma from chondroblastic osteosarcoma through IDH1/2 mutations.
Kerr DA; Lopez HU; Deshpande V; Hornicek FJ; Duan Z; Zhang Y; Rosenberg AE; Borger DR; Nielsen GP
Am J Surg Pathol; 2013 Jun; 37(6):787-95. PubMed ID: 23598960
[TBL] [Abstract][Full Text] [Related]
28. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
[TBL] [Abstract][Full Text] [Related]
29. Ezrin immunohistochemical expression in chondrosarcomas, osteosarcomas and Ewing sarcoma family of tumors.
Machado I; Navarro S; Giner F; Alberghini M; Bertoni F; Llombart-Bosch A
Virchows Arch; 2010 Jul; 457(1):87-9. PubMed ID: 20552365
[No Abstract] [Full Text] [Related]
30. Vascular endothelial growth factor expression as a biomarker of prognosis in patients with chondrosarcoma, Ewing's sarcoma and osteosarcoma. Current concepts.
Capasso L; Florio M; Lillo M; Basilico M; De Santis V; Ziranu A; Grasso A; Minutillo F; Maccauro G
J Biol Regul Homeost Agents; 2019; 33(2 Suppl. 1):39-43. . XIX Congresso Nazionale S.I.C.O.O.P. Societa' Italiana Chirurghi Ortopedici Dell'ospedalita' Privata Accreditata. PubMed ID: 31169001
[TBL] [Abstract][Full Text] [Related]
31. [Interdisciplinary diagnostic and treatment of bone sarcomas of the extremities and trunk].
Andreou D; Hardes J; Gosheger G; Henrichs MP; Nottrott M; Streitbürger A
Handchir Mikrochir Plast Chir; 2015 Apr; 47(2):90-9. PubMed ID: 25897578
[TBL] [Abstract][Full Text] [Related]
32. [Immunohistochemical localization of bone Gla protein and osteonectin in normal human bone and cartilage tissues, and in osteosarcomas and chondrosarcomas].
Chiba H; Matsuyama T
Nihon Seikeigeka Gakkai Zasshi; 1993 May; 67(5):463-72. PubMed ID: 8336066
[TBL] [Abstract][Full Text] [Related]
33. The Utility of MDM2 and CDK4 Immunohistochemistry and MDM2 FISH in Craniofacial Osteosarcoma.
Limbach AL; Lingen MW; McElherne J; Mashek H; Fitzpatrick C; Hyjek E; Mostofi R; Cipriani NA
Head Neck Pathol; 2020 Dec; 14(4):889-898. PubMed ID: 32026294
[TBL] [Abstract][Full Text] [Related]
34. Karyopherin Alpha 2 Is an Adverse Prognostic Factor in Clear-Cell and Papillary Renal-Cell Carcinoma.
Müller T; Tolkach Y; Stahl D; Steiner S; Hauser S; Ellinger J; Rabien A; Ralla B; Jung K; Stephan C; Kristiansen G
Clin Genitourin Cancer; 2019 Feb; 17(1):e167-e175. PubMed ID: 30448104
[TBL] [Abstract][Full Text] [Related]
35. Characterization of CXCR4 expression in chondrosarcoma of bone.
Bai S; Wang D; Klein MJ; Siegal GP
Arch Pathol Lab Med; 2011 Jun; 135(6):753-8. PubMed ID: 21631268
[TBL] [Abstract][Full Text] [Related]
36. Nuclear p63 expression in osteoblastic tumors.
Kallen ME; Sanders ME; Gonzalez AL; Black JO; Keedy VL; Hande KR; Homlar KC; Halpern JL; Holt GE; Schwartz HS; Coffin CM; Cates JM
Tumour Biol; 2012 Oct; 33(5):1639-44. PubMed ID: 22623071
[TBL] [Abstract][Full Text] [Related]
37. Utility of immunohistochemical analysis for cyclo-oxygenase 2 in the differential diagnosis of osteoblastoma and osteosarcoma.
Hosono A; Yamaguchi U; Makimoto A; Endo M; Watanabe A; Shimoda T; Kaya M; Matsumura T; Sonobe H; Kusumi T; Yamaguchi T; Hasegawa T
J Clin Pathol; 2007 Apr; 60(4):410-4. PubMed ID: 16822878
[TBL] [Abstract][Full Text] [Related]
38. [MRI morphology of bone tumors and tumor-like lesions].
Erlemann R
Radiologe; 2010 Jan; 50(1):61-80; quiz 81. PubMed ID: 19609499
[TBL] [Abstract][Full Text] [Related]
39. The ultrastructure of small-cell osteosarcoma, with a review of the light microscopy and differential diagnosis.
Dickersin GR; Rosenberg AE
Hum Pathol; 1991 Mar; 22(3):267-75. PubMed ID: 2004750
[TBL] [Abstract][Full Text] [Related]
40. Serum concentrations of sCD30 and sCD40L in patients with malignant bone tumours.
Holzer G; Pfandlsteiner T; Blahovec H; Trieb K; Kotz R
Wien Med Wochenschr; 2003; 153(1-2):40-2. PubMed ID: 12621691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
